A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...
Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...
Bharat Biotech has launched India's first vertically integrated cell and gene therapy facility in Telangana, investing USD 75 ...
Hyderabad: Bharat Biotech International Limited (BBIL), has announced the launch of India's only vertically integrated, ...
Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is ...
Vaccine manufacturer Bharat Biotech International Limited (BBIL) is making a foray into the cell and gene therapy (CGT) space ...
BBIL's 50,000-square-foot CGT facility advances its mission to deliver life-saving treatments for haematological malignancies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results